3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
2
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
2
Vascular Malformations
1
Triple Negative Breast Neoplasms
1
Peutz-Jeghers Syndrome
1
Perivascular Epithelioid Cell Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Malignant Solid Tumors
1
Lymphangioma
1
Lymphangioleiomyomatosis
1
Leiomyoma
1
Kaposiform Hemangioendothelioma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Neoplasms
1
Hemangioendothelioma
1
Graft vs Host Disease
1
Epilepsy
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Advanced Solid Tumors
1
Interventions
Vigabatrin
1
Therapeutic Touch
1
Sirolimus
1
Neuropsychological Tests
1
Medical Marijuana
1
Fluid Therapy
1
Aspirin
1
Anticonvulsants
1
Activator Appliances
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Epilepsy
×
Sirolimus
×
Clear all
NCT04987463
2024-02-08
ViRap
Children's Memorial Health Institute, Poland
Phase 2/3
Unknown
60 enrolled